2021-02-26T18:34:13+01:00
Feb 26, 2021
·
1 min read
In an article by Yuval Noah Harari at the Financial Times, he talks about how Israel has “vaccines for data” deal with the company Pfizer:
Meanwhile, Israel has the seventh highest average confirmed case rate, and to counter the disaster it resorted to a “vaccines for data” deal with the American corporation Pfizer. Pfizer agreed to provide Israel with enough vaccines for the entire population, in exchange for huge amounts of valuable data, raising concerns about privacy and data monopoly, and demonstrating that citizens’ data is now one of the most valuable state assets.
Read more about it also in an article titled “Vaccines For Data: Israel’s Pfizer Deal Drives Quick Rollout — And Privacy Worries” at NPR.org.
Authors
Wouter Van Rossem is a researcher on the intersection between social science and computer science. He previously worked on the European Research Council (ERC) funded project, Processing Citizenship, where he investigated how data infrastructures for population processing co-produce citizens, Europe, and territory. He completed his PhD at the University of Twente in the Netherlands and is still working on publications stemming from these impactful projects. In addition to his academic pursuits as a PhD at the University of Twente in the Netherlands, he brings a diverse background as a software engineer, having worked in various companies and at the European Commission’s Joint Research Centre in Italy. His diverse background, spanning both theoretical and hands-on knowledge, reflects his keen interest in exploring the intricate interconnections between technology and society.